Document and Entity Information
Document and Entity Information | Nov. 13, 2023 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Nov. 13, 2023 |
Entity File Number | 001-40782 |
Entity Registrant Name | Roivant Sciences Ltd. |
Entity Central Index Key | 0001635088 |
Entity Incorporation, State or Country Code | D0 |
Entity Tax Identification Number | 98-1173944 |
Entity Address, Address Line One | 7th Floor |
Entity Address, Address Line Two | 50 Broadway |
Entity Address, City or Town | London |
Entity Address, Country | GB |
Entity Address, Postal Zip Code | SW1H 0DB |
City Area Code | 207 |
Local Phone Number | 400-3347 |
Title of 12(b) Security | Common Shares, $0.0000000341740141 par value per share |
Trading Symbol | ROIV |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | true |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |